TS Picks: September 17, 2014

Stem cell trials; genetic engineering and citrus greening; appreciating postdocs

Tracy Vence
Sep 16, 2014

FLICKR, US DEPARTMENT OF AGRICULTURE

Selected stories from The Scientist’s reading list:

  • As researchers in Japan embark on the first clinical trial evaluating induced pluripotent stem cells (iPSCs) for age-related macular degeneration, The New York Times surveys the stem cell clinical trial landscape. “Progress comes in fits and starts,” the Harvard Stem Cell Institute’s David Scadden told the Times, adding: “when we look back 20 years from now, I think medicine and human health will be transformed by [stem cell research].”
     
  • Genetic engineering (GE) could save the Florida orange from citrus greening, National Geographic reports, but “one great remaining question is whether consumers will drink juice from genetically modified oranges.” (For even more on consumer acceptance of GE crops, see The Scientist’s June issue, dedicated to food.)
     
  • The US-based National Postdoctoral Association is celebrating its fifth-annual Postdoc Appreciation Week. Meanwhile, NPR’s Shots...

Interested in reading more?

<em>TS</em> Picks: September 17, 2014

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?